 |
|
|
|
|
Table of Contents
TABLE OF CONTENTS
LIST OF EXHIBITS
EXECUTIVE SUMMARY
METHODOLOGY
1.0 US DIABETIC VASCULAR DISEASE TREATMENT DEVICE MARKET
- 1.1 Market Overview
- 1.2 Diabetes Mellitus
- 1.2.1 Patient Population
- 1.2.2 Diabetic Vascular Disease
- 1.2.3 Macrovascular Complications of Diabetes
- 1.2.3.1 Diabetic Coronary Artery Disease
- 1.2.4 Microvascular Complications of Diabetes
- 1.2.4.1 Diabetic Nephropathy
- 1.2.4.2 Diabetic Neuropathy
- 1.2.4.3 Diabetic Retinopathy
- 1.2.5 Market Drivers & Limiters
2.0 DIABETIC CORONARY REVASCULARIZATION MARKET
- 2.1 Market Overview
- 2.1.1 Diabetic Coronary Artery Disease
- 2.1.2 Treatment Options
- 2.1.2.1 Medical Management
- 2.1.2.2 Coronary Revascularization
- 2.1.3 PCI versus CABG in Patients with Diabetes
- 2.1.3.1 Ongoing Clinical Trials
- 2.2 Market Analysis
- 2.2.1 Coronary Revascularization Procedures
- 2.2.1.1 PCI
- 2.2.1.2 CABG Surgery
- 2.2.2 Market Forecast
- 2.2.2.1 Diabetic Coronary Stents
- 2.2.2.2 PTCA Balloon Catheters
- 2.2.2.3 Coronary Atherectomy Devices
- 2.2.3 Market Drivers & Limiters
- 2.3 Competitive Analysis
3.0 DIABETIC NEPHROPATHY MARKET
- 3.1 Market Overview
- 3.2 Diabetic Nephropathy
- 3.3 Market Analysis
- 3.3.1 Arteriovenous Access Procedures
- 3.3.1.1 Native AV Fistula
- 3.3.1.2 Synthetic AV Graft
- 3.3.1.3 Dialysis Catheter
- 3.3.2 AV Access Management
- 3.3.2.1 AV POBA Procedures
- 3.3.2.2 AV Thrombectomy Procedures
- 3.3.3 Market Forecast
- 3.3.3.1 Dialysis Catheters in Diabetic Hemodialysis Patients
- 3.3.3.2 Synthetic AV Grafts
- 3.3.3.3 PTA Balloon Catheters for AV Access Management
- 3.3.3.4 Thrombectomy Devices for AV Access Management
- 3.3.4 Market Drivers & Limiters
- 3.4 Competitive Analysis
4.0 DIABETIC NEUROPATHY MARKET
- 4.1 Market Overview
- 4.2 Diabetic Neuropathy
- 4.3 Market Analysis
- 4.3.1 Lower Extremity Revascularization Procedures
- 4.3.1.1 PV Stent Procedures
- 4.3.1.2 PTA Procedures
- 4.3.1.3 Peripheral Atherectomy Procedures
- 4.3.1.4 Lower Extremity Bypass Procedures
- 4.3.2 Market Forecast
- 4.3.2.1 PV Stents
- 4.3.2.2 PTA Balloon Catheters
- 4.3.2.3 Peripheral Atherectomy Devices
- 4.3.2.4 Synthetic Bypass Graft Market
- 4.3.3 Market Drivers & Limiters
- 4.4 Competitive Analysis
List of Exhibits
EXECUTIVE SUMMARY
- Exhibit 1: Diabetic Vascular Disease Treatment Device Market, US (US$),
2006-2012
- Exhibit 2: Diabetic Coronary Revascularization Procedures, as a % of
Total, US, 2007 and 2012
- Exhibit 3: Diabetic Nephropathy Market, US (US$), 2006-2012
- Exhibit 4: Diabetic Neuropathy Market, as a % of Total, US, 2006-2012
METHODOLOGY
CHAPTER 1: US DIABETIC VASCULAR DISEASE TREATMENT DEVICE MARKET
- Exhibit 5: Diabetic Vascular Disease Treatment Device Market, US (US$),
2006-2012 (Graphical Format)
- Exhibit 6: Diabetic Vascular Disease Treatment Device Market, US (US$),
2006-2012 (Tabular Format)
- Exhibit 7: Total Prevalent and Diagnosed Cases of Diabetes Mellitus, by
Type, US, 2006-2012
- Exhibit 8: Prevalent and Diagnosed Cases of Diabetic Nephropathy,
Neuropathy, and Retinopathy, US, 2006-2012
- Exhibit 9: Drivers of the Diabetic Vascular Disease Treatment Device
Market, US, 2007
- Exhibit 10: Limiters of the Diabetic Vascular Disease Treatment Device
Market, US, 2007
CHAPTER 2: DIABETIC CORONARY REVASCULARIZATION MARKET
- Exhibit 11: Diabetic Coronary Revascularization Market, US (US$),
2006-2012 (Graphical Format)
- Exhibit 12: Diabetic Coronary Revascularization Market, US (US$),
2006-2012 (Tabular Format)
- Exhibit 13: Ongoing Clinical Trials in Diabetic Coronary Revascularization
- Exhibit 14: Treatment Algorithm for Patients with Diabetic Coronary Artery
Disease, US, 2007
- Exhibit 15: Total Coronary Revascularization Procedures, by Type, US,
2006-2012
- Exhibit 16: Diabetic Penetration in Coronary Revascularization Procedures,
by Segment, US, 2006-2012
- Exhibit 17: Diabetic Coronary Revascularization Procedures, by Type, US,
2006-2012
- Exhibit 18: Diabetic PCI Procedures, by Type, as a % of Total, US,
2006-2012
- Exhibit 19: Diabetic Stent Procedures, by Type, US, 2006-2012
- Exhibit 20: Diabetic Stent Procedures, by Device Type, US, 2006-2012
- Exhibit 21: Diabetic PTCA Balloon Procedures, by Type, 2006-2012
- Exhibit 22: Diabetic Coronary Atherectomy Procedures, by Subsequent PCI
Treatment, US, 2006-2012
- Exhibit 23: Diabetic CABG Procedures, by Type, 2006-2012
- Exhibit 24: Diabetic Stent Market, by Device Type, US (US$), 2006-2012
(Tabular Format)
- Exhibit 25: Diabetic Stent Market Growth, by Device Type, US, 2007-2012
- Exhibit 26: Diabetic Stent Market, US (US$), 2006-2012 (Graphical Format)
- Exhibit 27: Diabetic Coronary Stents, by Type, US, 2006-2012
- Exhibit 28: Diabetic PTCA Balloon Catheter Market, US (US$), 2006-2012
- Exhibit 29: Diabetic PTCA Balloon Catheter Market, US, 2006-2012
- Exhibit 30: Diabetic Coronary Atherectomy Market, US (US$), 2006-2012
(Graphical Format)
- Exhibit 31: Coronary Atherectomy Market, US (US$), 2006-2012 (Tabular
Format)
- Exhibit 32: Drivers of the Diabetic Coronary Revascularization Market, US
- Exhibit 33: Limiters of the Diabetic Coronary Revascularization Market, US
- Exhibit 34: Leading Competitors in the Coronary Revascularization Market,
US, 2007 (Tabular Format)
CHAPTER 3: DIABETIC NEPHROPATHY
- Exhibit 38: Diabetic Nephropathy Market, US, 2006-2012
- Exhibit 39: Diabetic Nephropathy Market, US (US$), 2006-2012 (Tabular
Format)
- Exhibit 35: Prevalent Cases of Diabetic Nephropathy, US, 2006-2012
- Exhibit 36: Prevalent Cases of Diabetic Nephropathy, by Severity, US,
2006-2012
- Exhibit 37: Prevalence and Incidence of ESRD and Diabetic ESRD, US,
2006-2012
- Exhibit 40: Prevalent Diabetic ESRD Population on Hemodialysis, by Mode of
AV Access, US, 2006-2012
- Exhibit 41: Incident ESRD and Diabetic ESRD, by Initial Treatment
Modality, US, 2006-2012
- Exhibit 42: Incident Diabetic ESRD Patients on Hemodialysis, by Mode of AV
Access, as a % of Total US, 2006-2012
- Exhibit 43: Incident Diabetic Hemodialysis Patients with DC for Vascular
Access, by DC Type, US, 2006-2012
- Exhibit 44: Treatment Algorithm for Incident Diabetic ESRD, US, 2007
- Exhibit 45: Treatment Algorithm for Prevalent Diabetic ESRD, US, 2007
- Exhibit 46: AV Access Management Procedures, US, 2006-2012
- Exhibit 47: AV POBA Procedures in Diabetic Patients, by Type of AV Access,
US, 2006-2012
- Exhibit 48: DC Units in Incident Diabetic Patients, by DC Type, US,
2006-2012
- Exhibit 49: DC Units in Net Surviving Diabetic Patients from Previous
Year, US, 2006-2012
- Exhibit 50: DC Units in Graft/Fistula Revision Procedures, by Type of AV
Access, US, 2006-2012
- Exhibit 51: DC Units in Prevalent Diabetic Hemodialysis Patients, by DC
Type, US, 2006-2012
- Exhibit 52: Diabetic Dialysis Catheter Market, US, 2006-2012 (Graphical
Format)
- Exhibit 53: Diabetic Dialysis Catheter Market, by Type, As a % of Total
US, 2006-2012
- Exhibit 54: Diabetic Dialysis Catheter Market Growth, by Type, US,
2007-2012
- Exhibit 55: Diabetic Synthetic AV Graft Market, US (US$), 2006-2012
(Graphical Format)
- Exhibit 56: Diabetic Synthetic AV Graft Market, US (US$), 2006-2012
(Tabular Format)
- Exhibit 57: Diabetic Arteriovenous PTA Balloon Catheter Market, US,
2006-2012 (Graphical Format)
- Exhibit 58: Diabetic Arteriovenous PTA Balloon Catheter Market, US,
2006-2012 (Tabular Format)
- Exhibit 59: Diabetic AV Thrombectomy Market, US (US$), 2006-2012
(Graphical Format)
- Exhibit 60: Diabetic AV Thrombectomy Market, US (US$), 2006-2012 (Tabular
Format)
- Exhibit 61: Drivers of the Diabetic Nephropathy Market, US, 2007
- Exhibit 62: Limiters of the Diabetic Nephropathy Market, US, 2007
- Exhibit 63: Leading Competitors in the Diabetic Nephropathy Market, US,
2007
CHAPTER 4: DIABETIC NEUROPATHY
- Exhibit 64: Diabetic Neuropathy Market, US, 2006-2012 (Graphical Format)
- Exhibit 65: Diabetic Neuropathy Market, US, 2006-2012 (Tabular Format)
- Exhibit 66: Treatment Algorithm for Incident Cases of Diabetic Lower
Extremity Vascular Disease, US, 2007
- Exhibit 67: Diabetic ATK Revascularization Procedures, by Device Type, US,
2006-2012
- Exhibit 68: Diabetic BTK Revascularization Procedures, by Device Type, US,
2006-2012
- Exhibit 69: Total Diabetic Lower Extremity Revascularization Procedures,
by Device Type, US, 2006-2012 (Tabular Format)
- Exhibit 70: Total Diabetic Lower Extremity Revascularization Procedures,
by Device Type, US, 2006-2012 (Graphical Format)
- Exhibit 71: Lower Extremity Revascularization Procedures, as a % of Total,
US, 2006-2012
- Exhibit 72: Diabetic PV Stent Market, US (US$), 2006-2012 (Graphical
Format)
- Exhibit 73: Diabetic PV Stent Market, by Indication, US, 2006-2012
(Tabular Format)
- Exhibit 74: Diabetic PV Stent Market Growth, by Indication US, 2006-2012
- Exhibit 75: Diabetic PTA Balloon Catheter Market, US (US$), 2006-2012
(Graphical Format)
- Exhibit 76: Diabetic PTA Balloon Catheter Market, US (US$), 2006-2012
(Tabular Format)
- Exhibit 77: Diabetic Peripheral Atherectomy Device Market, US (US$),
2006-2012 (Graphical Format)
- Exhibit 78: Diabetic Peripheral Atherectomy Device Market, US (US$),
2006-2012 (Tabular Format)
- Exhibit 79: Diabetic Synthetic Bypass Graft Market, US (US$), 2006-2012
(Graphical Format)
- Exhibit 80: Diabetic Synthetic Bypass Grafts Market, by Indication, US
(US$), 2006-2012 (Tabular Format)
- Exhibit 81: Drivers of the Diabetic Neuropathy Market, US, 2007
- Exhibit 82: Limiters of the Diabetic Neuropathy Market, US
- Exhibit 83: Leading Competitors in the Diabetic Neuropathy Market, US, 2007
|
|
|
|
|
|
View Cart
